The drugmaker already filed for approval for the age group in Canada and Europe.
In a study of nearly 2,500 kids aged 12 to 17, the vaccine was 100 percent effective against COVID-19. Moderna said it was also 93 percent effective against mild disease 14 days after a single dose.
No significant safety concerns were discovered in the trial, and the most common side effect was injection site pain.
Read Moderna’s full news release here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
